Sulfisoxazole structure
|
Common Name | Sulfisoxazole | ||
---|---|---|---|---|
CAS Number | 127-69-5 | Molecular Weight | 267.304 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 482.2±55.0 °C at 760 mmHg | |
Molecular Formula | C11H13N3O3S | Melting Point | 195°C | |
MSDS | Chinese USA | Flash Point | 245.4±31.5 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of SulfisoxazoleSulfisoxazole, an endothelin receptor antagonist, is a sulfonamide antibacterial with an oxazole substituent.Target: Antibacterial; Endothelin ReceptorThe sulfanilamide antibacterial agent sulfisoxazole was found to be a good endothelin receptor antagonist (IC50's of 0.60 microM and 22 microM for the ETA and ETB receptors, respectively) [1]. Sulfisoxazole is used to treat or prevent infections in many different parts of the body. It belongs to the group of medicines known as sulfonamide antibiotics. It works by preventing the growth of bacteria [2]. |
Name | sulfisoxazole |
---|---|
Synonym | More Synonyms |
Description | Sulfisoxazole, an endothelin receptor antagonist, is a sulfonamide antibacterial with an oxazole substituent.Target: Antibacterial; Endothelin ReceptorThe sulfanilamide antibacterial agent sulfisoxazole was found to be a good endothelin receptor antagonist (IC50's of 0.60 microM and 22 microM for the ETA and ETB receptors, respectively) [1]. Sulfisoxazole is used to treat or prevent infections in many different parts of the body. It belongs to the group of medicines known as sulfonamide antibiotics. It works by preventing the growth of bacteria [2]. |
---|---|
Related Catalog | |
References |
[2]. http://www.mayoclinic.org/drugs-supplements/sulfisoxazole-oral-route/description/drg-20072998 |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 482.2±55.0 °C at 760 mmHg |
Melting Point | 195°C |
Molecular Formula | C11H13N3O3S |
Molecular Weight | 267.304 |
Flash Point | 245.4±31.5 °C |
Exact Mass | 267.067749 |
PSA | 106.60000 |
LogP | 1.01 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.626 |
Storage condition | 2-8°C |
Stability | Stable. Incompatible with strong oxidizing agents. |
Water Solubility | <0.1 g/100 mL at 22.5 ºC |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 2 |
RTECS | WO9100000 |
HS Code | 2935009090 |
Precursor 9 | |
---|---|
DownStream 4 | |
HS Code | 2935009090 |
---|---|
Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... |
|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins
Bioorg. Med. Chem. 17 , 896-904, (2009) This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret... |
|
Fast determination of 22 sulfonamides from chicken breast muscle using core-shell nanoring amino-functionalized superparamagnetic molecularly imprinted polymer followed by liquid chromatography-tandem mass spectrometry.
J. Chromatogr. A. 1345 , 17-28, (2014) A novel, simple and sensitive method was developed for the simultaneous determination of 22 sulfonamides (SAs) in chicken breast muscle by using the dispersive micro-solid-phase extraction (d-μ-SPE) p... |
4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide |
4-Amino-N-(3,4-dimethylisoxazol-5-yl)-benzenesulfonamide |
4-Amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide |
Gantrizin |
Sulfisoxazole |
T5NOJ CMSWR DZ& D1 E1 |
N1-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide |
Benzenesulfonamide, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)- |
Sulfafurazole |
EINECS 204-858-9 |
MFCD00003150 |
4-Amino-N-(3,4-d |
5-(p-Aminobenzenesulfonamido)-3,4-dimethylisooxazole |
4-Amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide |